tiprankstipranks
Trending News
More News >
Cellectar Biosciences (CLRB)
NASDAQ:CLRB
US Market

Cellectar Biosciences (CLRB) Financial Statements

Compare
1,434 Followers

Cellectar Biosciences Financial Overview

Cellectar Biosciences's market cap is currently $16.11M. The company's EPS TTM is $-1.41; its P/E ratio is -0.38; Cellectar Biosciences is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-1.22. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -51.78M$ -38.96M$ -28.81M$ -24.13M$ -15.29M
EBITDA$ -51.49M$ -38.77M$ -28.67M$ -23.98M$ -14.89M
Net Income$ -44.58M$ -42.77M$ -31.79M$ -24.12M$ -15.09M
Balance Sheet
Cash & Short-Term Investments$ 23.29M$ 9.56M$ 19.87M$ 35.70M$ 57.17M
Total Assets$ 25.47M$ 12.08M$ 21.59M$ 37.20M$ 58.66M
Total Debt$ 494.00K$ 552.98K$ 603.83K$ 301.74K$ 421.64K
Net Debt$ -22.79M$ -9.01M$ -19.26M$ -35.40M$ -56.74M
Total Liabilities$ 11.18M$ 25.85M$ 12.05M$ 4.16M$ 3.86M
Stockholders' Equity$ 14.29M$ -13.78M$ 9.54M$ 33.05M$ 54.79M
Cash Flow
Free Cash Flow$ -47.69M$ -33.24M$ -25.45M$ -22.71M$ -14.00M
Operating Cash Flow$ -47.58M$ -32.38M$ -25.22M$ -22.57M$ -13.93M
Investing Cash Flow$ -104.19K$ -864.04K$ -225.97K$ -141.36K$ -62.35K
Financing Cash Flow$ 61.41M$ 22.94M$ 9.61M$ 1.25M$ 60.55M
Currency in USD

Cellectar Biosciences Earnings and Revenue History

Cellectar Biosciences Debt to Assets

Cellectar Biosciences Cash Flow

Cellectar Biosciences Forecast EPS vs Actual EPS